Abstract

FRUCTOOLIGOSACCHARIDE (FOS)- A SMART STRATEGY TO MODULATE INFLAMMATORY MARKER AND LIPID PROFILE IN NON INSULIN DEPENDENT DIABETES MELLITUS (NIDDM) SUBJECTS RESIDING IN ASSAM, INDIA- A RANDOMIZED CONTROL TRIAL.

Mini Sheth*, Abnita Thakuria, Vasundhra Chand and Dr. Mridu Paban Nath

Abstract

Introduction Diabetes mellitus is an important risk factor for CVD. Currently, Fructooligosaccharide (FOS) has been recognized for its potential to improve glycemic, lipemic control and reduce the expression of inflammatory markers. Objective: The study was designed with the broad objective to assess the effect of FOS supplementation to the pre hypertensive type 2 NIDDM subjects in terms of glycemia, lipemia, BMI and hs-CRP levels. Methodology: Using the randomized control trial study design, 35 pre hypertensive adults with type 2 NIDDM aged 35-55yrs were purposively selected from Sun Valley Hospital, Guwahati, Assam, and were randomly divided into Control(N=10) and FOS group (N=25). Background information was collected for glycemia, lipemia, hs-CRP and BMI. The FOS group was supplemented with 10ml of liquid FOS daily to be taken along with meals, for 45 days and post data was collected on the parameters similar to the baseline. Results: FOS supplementation resulted in a significant reduction (p

Keywords: FOS, diabetes mellitus, hypertension, hs-CRP.